Atlas Trials

Phase II Study of Everolimus Beyond Progression

Clinical trial NCT02269670 · TERMINATED

Trial details

NCT number
NCT02269670
Sponsor
Emory University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast CancerRecurrent Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
Start date
2014-11-25
Primary completion
2021-01-25
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.